Orthopedic Devices - Australia & Oceania

  • Australia & Oceania
  • In Australia & Oceania, the Orthopedic Devices market market is estimated to achieve a revenue of US$0.69bn in the year 2024.
  • Looking ahead, the market is projected to experience a steady annual growth rate (CAGR 2024-2028) of 4.41%, which would lead to a market volume of US$0.82bn by 2028.
  • When compared globally, the United States is expected to generate the highest revenue in the Orthopedic Devices market market, reaching US$16,040.00m in 2024.
  • Australia's growing aging population is driving demand for orthopedic devices, making it a lucrative market for medical technology companies.

Key regions: United States, United Kingdom, France, Germany, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in Australia & Oceania is experiencing significant growth and development.

Customer preferences:
Customers in Australia & Oceania have shown a strong preference for technologically advanced and innovative orthopedic devices. They are seeking products that provide better patient outcomes, faster recovery times, and improved quality of life. This preference is driving the demand for advanced implants, prosthetics, and other orthopedic devices that incorporate cutting-edge materials and technologies. Additionally, customers in this region prioritize products that are durable, reliable, and have a proven track record of success.

Trends in the market:
One of the key trends in the Orthopedic Devices market in Australia & Oceania is the increasing adoption of minimally invasive surgical procedures. These procedures offer several benefits, including smaller incisions, reduced scarring, faster recovery times, and lower risk of complications. As a result, there is a growing demand for orthopedic devices that are specifically designed for minimally invasive surgeries. This includes instruments and implants that can be easily inserted through small incisions and provide optimal surgical outcomes. Another trend in the market is the rising prevalence of orthopedic conditions and injuries. Factors such as an aging population, sedentary lifestyles, and sports-related injuries contribute to the increasing demand for orthopedic devices in Australia & Oceania. As the population ages, the incidence of conditions such as osteoarthritis and osteoporosis is expected to rise, driving the need for joint replacement surgeries and related orthopedic devices.

Local special circumstances:
Australia & Oceania has a unique set of circumstances that influence the Orthopedic Devices market. One of these is the presence of a universal healthcare system in countries like Australia and New Zealand. This ensures that a significant portion of the population has access to orthopedic treatments and devices. Additionally, the region has a high standard of healthcare infrastructure, which enables the delivery of advanced orthopedic procedures and the use of innovative devices.

Underlying macroeconomic factors:
The economic growth and development in Australia & Oceania play a crucial role in the Orthopedic Devices market. As the region's economies continue to grow, there is an increase in disposable income and healthcare spending. This allows individuals to afford expensive orthopedic procedures and devices, driving market growth. Additionally, the presence of a well-established healthcare system and favorable reimbursement policies further support the market's development. In conclusion, the Orthopedic Devices market in Australia & Oceania is witnessing significant growth and development. Customer preferences for technologically advanced and innovative devices, the increasing adoption of minimally invasive surgical procedures, and the rising prevalence of orthopedic conditions and injuries are driving market trends. The presence of a universal healthcare system, high healthcare standards, and favorable macroeconomic factors contribute to the market's growth in this region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)